-
1
-
-
0031597388
-
12, and serum total homocysteine levels in confirmed Alzheimer disease
-
12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55:1449-1455
-
(1998)
Arch Neurol
, vol.55
, pp. 1449-1455
-
-
Clarke, R.1
Smith, A.D.2
Jobst, K.A.3
-
2
-
-
0037075257
-
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
-
Seshadri S, Beiser A, Selhub J, et al: Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483
-
(2002)
N Engl J Med
, vol.346
, pp. 476-483
-
-
Seshadri, S.1
Beiser, A.2
Selhub, J.3
-
3
-
-
0030915272
-
Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor
-
Lipton SA, Kim WK, Choi YB, et al: Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 1997; 94:5923-5928
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 5923-5928
-
-
Lipton, S.A.1
Kim, W.K.2
Choi, Y.B.3
-
4
-
-
0036523032
-
Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease
-
Kruman II, Kumaravel TS, Lohani A, et al: Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 2002; 22:1752-1762
-
(2002)
J Neurosci
, vol.22
, pp. 1752-1762
-
-
Kruman, I.I.1
Kumaravel, T.S.2
Lohani, A.3
-
5
-
-
2242477014
-
Lowering blood homocysteine with folic acid-based supplements: Metaanalysis of randomised trials
-
Homocysteine Lowering Trialists' Collaboration: Lowering blood homocysteine with folic acid-based supplements: metaanalysis of randomised trials. BMJ 1998; 316:894-898
-
(1998)
BMJ
, vol.316
, pp. 894-898
-
-
-
6
-
-
0033551352
-
The effect of folic acid fortification on plasma folate and total homocysteine concentrations
-
Jacques PF, Selhub J, Bostom AG, et al: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999; 340:1449-1454
-
(1999)
N Engl J Med
, vol.340
, pp. 1449-1454
-
-
Jacques, P.F.1
Selhub, J.2
Bostom, A.G.3
-
7
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group
-
McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group. Neurology 1984; 34:939-944
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
-
10
-
-
0024215746
-
Geriatric Depression Scale
-
Yesavage JA: Geriatric Depression Scale. Psychopharmacol Bull 1988; 24:709-711
-
(1988)
Psychopharmacol Bull
, vol.24
, pp. 709-711
-
-
Yesavage, J.A.1
-
11
-
-
0030900736
-
Novel reductant for determination of total plasma homocysteine
-
Gilfix BM, Blank DW, Rosenblatt DS: Novel reductant for determination of total plasma homocysteine. Clin Chem 1997; 43:687-688
-
(1997)
Clin Chem
, vol.43
, pp. 687-688
-
-
Gilfix, B.M.1
Blank, D.W.2
Rosenblatt, D.S.3
-
12
-
-
0029049553
-
A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
-
Frosst P, Blom HJ, Milos R, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10:111-113
-
(1995)
Nat Genet
, vol.10
, pp. 111-113
-
-
Frosst, P.1
Blom, H.J.2
Milos, R.3
|